Related Experiment Video
Updated: Oct 8, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial Fibrillation Following Coronary Artery Bypass Graft: Where Do We Stand?
Andreas Tzoumas1, Sanjana Nagraj2, Panagiotis Tasoudis3
1Aristotle University of Thessaloniki, Thessaloniki 541 24, Greece.
Insights
Post-coronary artery bypass graft (CABG) atrial fibrillation (AF) affects 15-45% of patients. Management includes cardioversion or rate control, with anticoagulation recommended for stroke risk, especially after cardioversion or prolonged AF.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a common complication after coronary artery bypass graft (CABG) surgery, occurring in 15-45% of patients.
- Post-CABG AF is linked to adverse long-term outcomes and prognosis.
- Risk factors for post-CABG AF are multifactorial, including patient-related, intraoperative, and postoperative elements.
Purpose of the Study:
- To review the prevalence, risk factors, and management strategies for atrial fibrillation following coronary artery bypass graft surgery.
- To outline current recommendations for therapeutic and preventive interventions for post-CABG AF.
- To discuss the complexities of anticoagulation in patients with post-CABG AF.
Main Methods:
- Literature review of studies on atrial fibrillation after coronary artery bypass graft surgery.
- Analysis of risk factors, diagnostic criteria, and treatment guidelines for post-CABG AF.
- Synthesis of evidence regarding cardioversion, rate control, and anticoagulation strategies.
Main Results:
- Post-CABG AF prevalence ranges from 15% to 45%.
- Management strategies vary based on patient stability and symptoms, including cardioversion and rate control.
- Anticoagulation is crucial for patients with stroke risk factors, particularly after cardioversion or persistent AF >48 hours, with a recommended minimum duration of 4 weeks.
Conclusions:
- Atrial fibrillation is a significant arrhythmia post-CABG, impacting patient prognosis.
- Effective management involves timely intervention with cardioversion or rate control and careful consideration of anticoagulation.
- Long-term anticoagulation should be individualized based on stroke risk, irrespective of AF recurrence.
Abstract:
Atrial fibrillation (AF) is the most common atrial arrhythmia following coronary artery bypass graft (CABG). Its prevalence is 15-45% and is associated with poor long-term prognosis. Risk factors can be patient-related, intraoperative, and/or postoperative. Therapeutic and preventive strategies have been developed to curtail AF burden. Cardioversion is recommended for unstable or symptomatic patients and rate control if asymptomatic. Anticoagulation is challenging with risk of thromboembolism and bleeding. However, patients should be anticoagulated after cardioversion or if AF persists >48 h and risk factors of stroke exist. A minimum of 4 weeks is recommended but longer duration should be considered in patients at high risk of stroke irrespective of recurrence of AF.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

